These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22842617)

  • 1. The impact of preoperative biological therapy on complications after abdominal surgery for inflammatory bowel disease.
    Yamamoto T; Shiraki M
    Gut; 2013 Mar; 62(3):475-6. PubMed ID: 22842617
    [No Abstract]   [Full Text] [Related]  

  • 2. Preoperative biological therapy and short-term outcomes of abdominal surgery in patients with inflammatory bowel disease.
    Waterman M; Xu W; Dinani A; Steinhart AH; Croitoru K; Nguyen GC; McLeod RS; Greenberg GR; Cohen Z; Silverberg MS
    Gut; 2013 Mar; 62(3):387-94. PubMed ID: 22619367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for the management of inflammatory bowel disease in adults.
    Carter MJ; Lobo AJ; Travis SP;
    Gut; 2004 Sep; 53 Suppl 5(Suppl 5):V1-16. PubMed ID: 15306569
    [No Abstract]   [Full Text] [Related]  

  • 4. Postoperative outcomes in vedolizumab-treated pediatric patients undergoing abdominal operations for inflammatory bowel disease.
    Lightner AL; Tse CS; Potter DD; Moir C
    J Pediatr Surg; 2018 Sep; 53(9):1706-1709. PubMed ID: 29111083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease-modifying anti-inflammatory bowel disease drugs (DMAIDs): the missing term in the literature.
    Peyrin-Biroulet L
    Am J Gastroenterol; 2013 May; 108(5):859-60. PubMed ID: 23644972
    [No Abstract]   [Full Text] [Related]  

  • 6. Why innovation in inflammatory bowel disease drug development will impact your practice.
    Sandborn WJ
    Clin Gastroenterol Hepatol; 2011 Mar; 9(3):211-3. PubMed ID: 21338946
    [No Abstract]   [Full Text] [Related]  

  • 7. Medical therapy of inflammatory bowel disease.
    Lichtenstein GR
    Gastroenterol Clin North Am; 2004 Jun; 33(2):xv-xvi. PubMed ID: 15177548
    [No Abstract]   [Full Text] [Related]  

  • 8. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter: infliximab therapy for patients with inflammatory bowel disease--some unanswered questions.
    Srinivas NR
    Aliment Pharmacol Ther; 2015 Nov; 42(9):1133. PubMed ID: 26427755
    [No Abstract]   [Full Text] [Related]  

  • 10. Novel treatments in inflammatory bowel disease.
    Pathmakanthan S; Stack WA
    Hosp Med; 1999 Jan; 60(1):19-23. PubMed ID: 10197093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative Vedolizumab and Postoperative Outcomes in Inflammatory Bowel Disease: Does Smoke Always Mean Fire?
    Kotze PG; Yamamoto T
    J Crohns Colitis; 2017 May; 11(5):643. PubMed ID: 28453769
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter: infliximab therapy for patients with inflammatory bowel disease--some unanswered questions. Authors' reply.
    Buurman DJ; Maurer JM; Keizer RJ; Kosterink JG; Dijkstra G
    Aliment Pharmacol Ther; 2015 Nov; 42(9):1134. PubMed ID: 26427756
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent advances in inflammatory bowel disease.
    Hunter J
    Br J Hosp Med (Lond); 2007 Jul; 68(7):350. PubMed ID: 17663303
    [No Abstract]   [Full Text] [Related]  

  • 14. Associations between the IGF system and inflammatory markers in inflammatory bowel disease.
    Grønbaek H; Eivindson MV
    Aliment Pharmacol Ther; 2006 Feb; 23(4):553-4; author reply 554-5. PubMed ID: 16441476
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter: infliximab therapy in inflammatory bowel disease patients after liver transplantation.
    Indriolo A; Fagiuoli S; Pasulo L; Fiorino G; Danese S; Ravelli P
    Aliment Pharmacol Ther; 2013 Apr; 37(8):840-2. PubMed ID: 23496317
    [No Abstract]   [Full Text] [Related]  

  • 16. What Proportion of Patients With Inflammatory Bowel Disease Want to Stop Infliximab Therapy?
    Conroy G; Clerc-Urmès I; Allen PB; Baumann C; Peyrin-Biroulet L
    Inflamm Bowel Dis; 2016 Jul; 22(7):E25-6. PubMed ID: 27271494
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biological drugs in inflammatory bowel disease: Management and care].
    Guerra I; Bermejo F
    Rev Esp Enferm Dig; 2015 Jul; 107(7):454. PubMed ID: 26140643
    [No Abstract]   [Full Text] [Related]  

  • 18. Current medical therapy for chronic inflammatory bowel diseases.
    Tamboli CP
    Surg Clin North Am; 2007 Jun; 87(3):697-725. PubMed ID: 17560421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory bowel disorders. Summary and table.
    Wagetaff A; Elkinson S
    Drugs R D; 1999 Mar; 1(3):245-50. PubMed ID: 10566036
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of the drug treatment regimens for inflammatory bowel disease.
    Brock EM; Zabihollah M
    Expert Opin Pharmacother; 1999 Nov; 1(1):15-8. PubMed ID: 11249558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.